Infection prevention

Information concerning the Ebola epidemic

By: Mölnlycke Health Care, February 3 2015Posted in: Infection prevention

January 2015

The outbreak of the Ebola virus in several West African countries, which has escalated with an increasing number of suspected, probable and confirmed cases, is now starting to cause concern globally. Naturally this has implications for the wider healthcare and medical community, and has given rise to many questions.

What we do know about Ebola is that human-to-human virus transmission occurs from direct contact through broken skin or mucous membranes with the blood or other bodily fluids or secretions (stool, urine, saliva, semen) of infected people. Given the methods of transmission, general guidelines from organisations, such as the World Health Organisation (WHO) and Centers for Disease Control (CDC), have emphasised infection prevention and control measures that healthcare facilities and professionals engage in already. Beyond that, the WHO has issued written guidelines1 that include recommendations for personal protection equipment when caring for patients infected with (or suspected to be infected with) the Ebola virus. These guidelines should be referred to first and foremost.

While Mölnlycke Health Care has not tested its products specifically for use in protection in treating patients infected with Ebola, we do offer products that are designed to fulfil infection control and barrier protection purposes, such as surgical gloves, gowns, face masks and so forth. For more detailed information on products fulfilling these needs, see the information below, where we have provided a range of products made from impermeable or fluid-repellant material, which protect against microorganism transfer, body fluids and particles.

Your local Mölnlycke Health Care representative will be happy to assist you with product information and availability questions.

It is important to clarify that Mölnlycke Health Care offers no products that have been tested specifically against the Ebola virus.

  Biogel surgical gloves

Biogel PI Indicator System

414

Biogel PI indicator Underglove and Biogel PI Ultratouch

416 and 409

Biogel Skinsense Underglove and Biogel Skinsense

406 and 509

 

BARRIER surgical gowns

BARRIER Surgical Gown FPP L

670102

BARRIER Surgical Gown FPP LL

670103

BARRIER Surgical Gown FPP XL

670104

BARRIER Surgical Gown FPP XLL

670105

BARRIER Surgical Gown FPP XXLL

670107

BARRIER Surgical Gown FPP L

6701021*

BARRIER Surgical Gown FPP LL

6701031*

BARRIER Surgical Gown FPP XL

6701041*

BARRIER Surgical Gown FPP XLL

6701051*

BARRIER Surgical Gown FPP XXLL

6701071*

*Australian codes

 

BARRIER Scrub suits

BARRIER Scrub shirt, S, blue and green

21610, 18610

BARRIER Scrub shirt, M, blue and green

21620, 18620

BARRIER Scrub shirt, L, blue and green

21630, 18630

BARRIER Scrub shirt, XL, blue and green

21640, 18640

BARRIER Scrub shirt, XXL, blue and green

21650, 18650

BARRIER Scrub shirt, XXXL, blue and green

21660, 18660

BARRIER Scrub shirt, XXXXL, blue and green

21670, 18670

BARRIER Scrub pants, S, blue and green

21710, 18710

BARRIER Scrub pants, M, blue and green

21720, 18720

BARRIER Scrub pants, L, blue and green

21730, 18730

BARRIER Scrub pants, XL, blue and green

21740, 18740

BARRIER Scrub pants, XXL, blue and green

21750, 18750

BARRIER Scrub pants, XXXL, blue and green

21760, 18760

BARRIER Scrub pants, XXXXL, blue and green

21770, 18770

 

More information and references:

  1. WHO, Interim Infection Prevention and Control Guidance for Care of Patients with Suspected or Confirmed Filovirus Haemorrhagic Fever in Health-Care Settings, with Focus on Ebola: http://www.who.int/csr/resources/who-ipc-guidance-ebolafinal-09082014.pdf?ua=1
  2. WHO, Frequently answered questions regarding Ebola: http://www.who.int/csr/disease/ebola/faq-ebola/en/
  3. Centers of Disease Control (CDC), US: http://www.cdc.gov/vhf/ebola/hcp/infection-prevention-and-control-recommendations.html
  4. Department of Health, HSE and Advisory committee on dangerous pathogens, UK:https://www.gov.uk/government/uploads/system/uploads/attachment_data/file/343185/ACDP_VHF_guidance_12_08_20141.pdf
  5. The National Board of Health and Welfare (Socialstyrelsen, Sweden): http://www.socialstyrelsen.se/Lists/Artikelkatalog/Attachments/19458/2014-6-7.pdf
  6. Pathogen safety data sheet- infectious substances, Public Health Agency of Canada Canada:http://www.phac-aspc.gc.ca/lab-bio/res/psds-ftss/ebola-eng.php

 

Please Note:  Use of protective apparel is only a single component of a comprehensive personal protective equipment (PPE) program recommended for response to the Ebola virus disease.  The information provided herein is not intended as a substitute for end-users performance of individual hazard assessments to determine the suitability of Mölnlycke Health Care products for their particular purpose.  It is provided as information only, and not as a product recommendation.

Share this

More from the same category

Reusable staff clothes carry harmful bacteria...

Mölnlycke Health Care, Surgical division comments on the paper ”Nursing and physician...

Mölnlycke voices support for WHO’s call-to-action...

Mölnlycke Health Care supports the goals of the recently-announced World Health Organisation...

Ebola virus – proposal for personal protective...

The recent outbreak of the Ebola virus in several West African countries, which has...